Our broad clinical rotations offer fellows the opportunity to work with subspecialty experts across The Mount Sinai Hospital, and with their high volume of patients and complex cases. Each clinical rotation provides extensive educational, hands-on clinical training and encourages exploring in-depth research opportunities.
In addition, the Cardiovascular Research Center at Mount Sinai offers opportunities for experiences in basic cellular and molecular research, channelopathy, pharmacogenetics, stem cell and regenerative therapy, as well as translational and early phase clinical trials.
Rotations of the The Cardiovascular Training Program at Mount Sinai Hospital of the Icahn School of Medicine:
Director: Anapoorna Kini, MD
Fellows have extensive structured training in one of the largest volume cardiac catheterization labs in the country under the supervision of some of the most respected thought leaders in the field. Total procedural volume is over 15,000, including over 5,000 coronary interventions; 376 transcatheter aortic valve replacements (TAVR); over 76 transcatheter mitral valve repair procedures; and 800 endovascular procedures.
Fellows evaluate patients for appropriateness of cardiac catheterization and are supervised performing the diagnostic procedures. First year fellows become proficient in venous and arterial access, interpretation of complex coronary angiograms and hemodynamics, assessment and management of acute coronary syndromes and mechanical support devices, including Impella devices, intra-aortic balloon pumps and left ventricular assist devices.
Second and Third year Fellows have increasing responsibilities and procedural participation and independence commensurate with their interests and career goals.
Fellows have the opportunity to be involved in the many national and international clinical trials led by the outstanding faculty in areas including anti-thrombotic therapy, valvular disease intervention, intracoronary imaging and physiology, new devices, and the development of APPs. The large Interventional and Structural Disease subspecialty program has given preference to our fellows.
Read about Mount Sinai Heart’s Cath lab
Center for Interventional Cardiovascular Research and Clinical Trials:
Program Director: Roxana Mehran, MD
The Center for Interventional Cardiovascular Research and Clinical Trials is dedicated to improving the care, quality and outcomes for patients with cardiovascular disease through innovative, patient-centered research. This center is a leading National and International resource in the generation of health data related to the prevention, diagnosis and treatment of cardiovascular disease. The Center runs large, multi-site, multi-phase clinical trials and registry studies both in the United States and with international partner sites around the world. The research generated by this Center has been published in some of the most prestigious journals in the medical community including the New England Journal of Medicine (NEJM), Journal of the American College of Cardiology (JACC), The Journal of the American Medical Association (JAMA), and The Lancet.
During elective rotations, fellows are involved in learning every aspect of clinical research under the tutelage of the Center’s senior clinical research faculty, and in synergistic collaboration with other prominent academic institutions. Fellows can apply for a dedicated year-long Research – Scholar position and be guided through the full lifecycle of the research process and leave prepared for successful careers in academic research.
Mount Sinai Electrophysiology:
Director: Vivek Y. Reddy, MD.
EP Lab and Director: Srinivas R. Dukkipati, MD
The goal of the Mount Sinai Heart Clinical Cardiac Electrophysiology program is to train cardiology fellows in the diagnosis and management of adult patients with complex cardiac arrhythmias through a robust consultative service, as well as invasive and noninvasive methods for evaluation for pharmacologic, device, and ablative forms of therapy under direct supervision of a world class faculty. Fellows become proficient in device interrogation and programing. The EP laboratory at Mount Sinai Hospital is one of the busiest in the region and its 10 faculty members are referred patients from around the world. Total procedure volume is in excess of 3,400 per year: over 1,000 atrial and ventricular ablations; more than 400 pacemakers; more than 350 implantable defibrillators, including cardiac resynchronization therapy; and implantation of over 100 percutaneous left atrial appendage occlusion devices.
The electrophysiology section at Mount Sinai Hospital is among the top centers in the world in EP Research. Areas of research include ventricular tachycardia, atrial fibrillation ablation technologies, and left atrial appendage occlusion devices. In addition to an extensive clinical research program, there is a very busy pre-clinical research laboratory that routinely investigates novel ablation technologies.
Explore the Mount Sinai’s Helmsley Center for Electrophysiology
Noninvasive Cardiology (Echocardiography, Nuclear Cardiology, Cardiac CT, Cardiac MR):
Director: Stamatios Lerakis, MD, PhD
Noninvasive Cardiology in Mount Sinai Hospital includes State of the Art Echocardiography, Nuclear Cardiology, Cardiac CT and Cardiac MR Laboratories. All these imaging modalities are staffed with expert faculty in each imaging field and equipped with cutting edge technology. All laboratories are extremely busy clinically and provide tremendous opportunities for research. The mission of Noninvasive Cardiology in Mount Sinai Hospital is to provide the best possible care to our patients, education for our fellows and research to teach our academic community.
Director: Lori Croft, MD
The Echocardiography Laboratory of Mount Sinai Heart, internationally renowned for its excellence, performs both outpatient and inpatient studies in multiple locations utilizing state-of-the-art technology. They perform approximately 130 diagnostic procedures a day including detailed transthoracic and transesophageal echocardiograms, treadmill and pharmacological stress tests, and guidance for interventional, structural heart interventions, and electrophysiological interventions. Faculty emphasize quality and appropriateness use criteria despite being one of the busiest labs in the country, with over 30,000 echocardiograms yearly including greater than 2,500 stress echos, 2,000 transesophagael echos, and 1,000 structural cases, which provides an ideal training environment for fellows.
During the First Year, following summer Boot Camp, fellows develop a proficiency in technical acquisition and interpretation of transthoracic echocardiograms. Studies are performed by sonographers and fellows and read together with attending physicians in dedicated didactic sessions.
In the Second Year fellows begin performing advanced procedures such as stress and transesophageal echocardiograms under supervision. Most fellows achieve Level II training, and while Level III training is possible in 3 years, it usually requires a dedicated additional year of training, which is available for interested trainees.
There are extensive supervised and mentored research opportunities including artificial intelligence and imaging, ultrasound enhancing agents (contrast echo), advanced echo techniques including left ventricular and left atrial strain, 3D echo and post processing, structural and interventional echo, diastology, stress echo, and collaboration with other sections.
Director: Steve Lin Liao, MD
The nuclear cardiology laboratory at The Mount Sinai Hospital is a state of the art lab performing all aspects of cardiac radionuclide imaging using GE Discovery NM530c Alcyone SPECT cameras. In addition to the basic ECG exercise stress test (over 840 per year) and cardiopulmonary exercise test (over 260 per year), our stress lab performs the full spectrum of nuclear cardiology diagnostic testing including stress perfusion imaging using technetium based radiotracers with attenuation correction (4,460 per year), thallium based viability studies (84 per year), gated planar and SPECT equilibrium radionuclide angiography for the assessment of ventricular size and function (24 per year), and technetium pyrophosphate studies for the diagnosis of TTR variant cardiac amyloidosis (140 per year). Our lab is an active participant in several ongoing clinical studies investigating TTR cardiac amyloid, working in close collaboration with our colleagues in adult cardiac genetics, congestive heart failure, and electrophysiology.
With our high clinical volume and state of the art technology, our lab is an ideal training area for cardiology fellows with an interest in nuclear cardiology specifically and for fellows interested in non-invasive cardiac imaging investigative studies.
The first year cardiology fellow will learn first-hand how to safely and efficiently perform all the different stress protocols as outlined by ASNC and appreciate all of their indications and contraindications. They will learn how to risk stratify patients based on their stress testing results and manipulate the software used in the lab for image interpretation (Myometrics and Cedars).
In the second and third years of training, the cardiology fellow will assume a more supervisory role, gain skill with the subjective and objective quantification and CT correction of anatomic perfusion abnormalities and generate initial full reports which are reviewed as a group during reading sessions. With proper planning, all fellows can gain level II training in nuclear cardiology to become board certified nuclear cardiologists.
Advanced Cardiac Imaging [Cardiac MR (CMR) , and Cardiac CT (CCT):
Director: Javier Sanz, MD
The Advanced Cardiac Imaging Program at Mount Sinai Hospital is a State of the Art Laboratory performing a wide spectrum of imaging for a broad spectrum of cardiovascular diseases in collaboration with the Cardiothoracic Imaging Division of Radiology. With the dedicated Philips Brilliance iCT 256 slice Cardiac CT scanner we perform approximately 5,000 CT’s per year which include calcium scores, coronary CT angiograms with multiple levels of complexity, coronary CT-FFR, CT’s for planning TAVR, percutaneous MVR and TVR and evaluation of complex vascular diseases of the aorta.
With the Siemens Avanto Dot 1.5T CMR system with all the latest available software, including T1 and T2 mapping we perform about 1,300 CMR studies annually. The CMR’s are done for LV and RV function and volume quantification, evaluation of valvular heart diseases, ischemic heart disease with pharmacological stress, viability, cardiac tumors, pericardial diseases, cardiomyopathies, adult congenital heart diseases and diseases of the aorta.
Under expert cardiology and radiology faculty supervision and superb CCT and CMR technicians, the fellows have the opportunity to participate in the acquisition and interpretation of these studies and participate in clinical and translational research involving cardiac and vascular disease detection, intervention and prevention.
Cardiac CT and CMR play an increasingly important role in clinical cardiology. There is a curriculum that covers both modalities that the fellows can attend during the rotation. Also through our collaboration with Radiology the fellows have the unique perspective from both Cardiology and Radiology.
Fellows can apply for the Advanced Cardiovascular Imaging Fellowship in CMR and Cardiac CT Program which prepares physicians for certification for level 3 training in both cardiac CT and CMR. There is one Fellowship position available per year.
Imaging for Structural Heart Interventions:
Director: Stamatios Lerakis, MD, PhD
Imaging for Structural Heart Interventions is a relatively new field in cardiac imaging that supports the Structural and Valve Interventions Program. Multimodality imaging , including echocardiography, cardiac CT, cardiac MRI, and in the near future with fusion imaging, is used for screening, planning, intraprocedural guidance and follow-up of a wide variety of percutaneous structural and valve interventions. Dr. Lerakis is a pioneer in imaging guidance of complex structural and valve procedures. Fellows have the opportunity participate in procedures and comparative research projects. Also fellows may apply for a one year dedicated Fellowship in Imaging for Structural Heart Interventions after completing a formal Cardiology Fellowship.
Cardiovascular Imaging Research:
Director: Zahi Fayad, PhD
Dr. Zahi Fayad is Director of the BioMedical Engineering and Imaging Institute (BMEII) and director of Cardiovascular Imaging Research at Mount Sinai. The center pioneers interdisciplinary research - from engineering to biology and from pre-clinical to clinical investigations, nanomedicine and nanotheranostics. The laboratory has a broad background in medical image acquisition and analysis as well as in conducting imaging multicenter clinical atherosclerosis trials (FDG-PET, CT, MR)
Dr. Fayad oversees a diverse team composed of physicists, engineers, computer scientists, and medical doctors with combined expertise on PET, CT, MR and hybrid imaging of cardiovascular, body and neuroimaging, as well as robotics, computer vision and machine learning. BMEII's mission is centered on the development, validation and translation of innovative biomedical engineering technologies applied to healthcare. To fulfill its mission, BMEII combines state-of-the-art facilities with outstanding faculty, technical staff scientists, and administrative support staff. BMEII has grown to 16 faculty members, 17 affiliated faculty, 9 adjunct faculty, 20 core staff, and 20 research staff.
Coronary Critical Care:
Director: Umesh Gidwani, MD
Associate Director: Matt Tomey, MD
The 1st year cardiology fellow supervises a team of medical residents taking care of complex cardiac conditions, including acute coronary syndromes, advanced heart failure, peri-procedural high risk coronary and structural interventions, malignant arrhythmias, and mechanical therapies including Impella devices, intra-aortic balloon pumps, ECMO and left ventricular assist devices. Our 20 bed (14 ICU and 6 Step Down) state of the art unit is supervised by both a Cardiologist and a Critical Care physician (providing 24/7 coverage). Fellows take call from home at night, but return for appropriate patient care.
Dr. Valentin Fuster Chief Service:
During their first and second years, fellows have the unique opportunity of working closely with Dr. Valentin Fuster for 8 to 10 weeks. Besides dealing with an extraordinarily diverse outpatient and inpatient population, fellows learn directly from the American College of Cardiology designated Legend in Cardiology.
Director: Donna Mancini
The mission of the Advanced Heart Failure and Cardiac Transplant Program is to extend and improve the lives of patients living with heart failure. Our program is staffed with 10 AHFTCs and collectively sees over 5,500 annual outpatient visits for patients with inherited and acquired forms of cardiomyopathy from our large hospital network, tristate area, and around the world. We work closely with a team of physicians from cardiac thoracic surgery and interventional cardiology to discuss acute and chronic HF and shock patients in consideration of advanced mechanical therapy (Ventricular Assist Devices (VAD), Total Artifiicial Heart, ECMO or cardiac transplant). In addition to offering a chronic HF disease management program, we have specialty clinics that focus on cardiac amyloidosis, cardiac sarcoidosis and hypertrophic cardiomyopathy. We partner with both advanced imaging and cardiac genetics to offer uniquely specialized diagnostics to our patients. Our program oversees about 30 heart transplants and 50 VAD implants annually, and we are the only program in NY that specializes in placing the total artificial heart. Our clinical and translational program has numerous research protocols and assistants who actively recruit patients and our faculty are always eager to mentor fellows on a research project.
Read about Mount Sinai’s Heart Failure and Transplantation Services
Directors: Jeffrey I. Mechanick, M.D (Endocrinologist) and Maryann McLaughlin, M.D. (Cardiologist and Director of Cardiac Rehabilitation and Medical Fitness)
The Cardiometabolic Service at Mount Sinai Heart provides comprehensive and durable care in an immersive environment to decrease the risks for development and progression of cardiovascular disease. In this clinical service line, cardiologists, endocrinologists, and general internists work together as a team in the Kravis Center for Clinical Cardiovascular Health at Mount Sinai Heart to provide a unique brand of individualized, evidence-based treatment. This first-in-class facility houses multiple programs for primary, secondary, and tertiary prevention of cardiovascular and metabolic disorders. These programs include: clinical medicine (general cardiology, general endocrinology, diabetes care, obesity care, nutritional and lifestyle medicine, and general internal medicine), certified cardiac rehabilitation, medical fitness, clinical nutrition and dietetics, and community engagement and educational curricula. Coordination of care is optimized through a seamless, inpatient consultative service at The Mount Sinai Hospital.
Fellows will develop specific skills in cardiovascular disease risk stratification,lifestyle medicine diagnostics and implementation,cardiac rehabilitation and medical fitness management,clinical nutrition, formulating disease-specific dietary plans, behavioral medicine and motivational interviewing,diabetes care and pharmacotherapy, obesity care and pharmacotherapy, dyslipidemia management, andongoing outpatient care of patients with cardiometabolic disorders, inpatient care of patients with cardiometabolic and nutritional disorders, and basics in management and operations of a Lifestyle Medicine Center. Research opportunities include, but are not limited to, transculturalization of cardiometabolic care using Venezuelan, Czech, and other databases, Adiposity-, Dysglycemia-, and Cardiometabolic-Based Chronic Disease modeling with various databases, and analysis of lifestyle medicine implementation and performance metrics with the Kravis Center database.
Mount Sinai Adult Congenital Heart Disease Center
Mount Sinai Heart
Mount Sinai Heart in collaboration with the Children’s Heart Center, Kravis Children’s Hospital, houses the Mount Sinai Adult Congenital Heart Disease Center (MSACHD) which provides comprehensive care to adolescent and adult patients with complex congenital heart disease (CHD). The program is directed by Ali N Zaidi, MD, nationally known Adult Congenital Heart Disease specialist. Dr. Zaidi is one of the few cardiologists in the country, who are boarded in Internal Medicine, Pediatrics, Adult Cardiovascular Disease and Pediatric Cardiology. Barry Love, MD is an integral part of the MSACHD Center and is an expert congenital interventionalist and has been providing care to patients of all ages with CHD for over two decades. Both Dr. Zaidi and Dr. Love are Board Certified in ACHD.
The MSACHD Center provides comprehensive care for patients with all forms of simple to complex cardiac lesions including. A total of six clinic sessions are held weekly where fellows can evaluate ACHD patients at all levels of complexity. The clinic also involves exposure to dedicated multi-modality imaging in CHD including echocardiography, CMR and CTA imaging. Fellows who have an interest in cardiac catheterization may choose to spend one day a week in the congenital cardiac catheterization suite where they will learn intracardiac hemodynamics, vasodilatory testing for patients with pulmonary hypertension and observe complex CHD interventions. The MSACHD Center also has two dedicated multidisciplinary clinics that are held once every other month. These include the Mount Sinai ACHD- Single Ventricle Fontan Clinic and the ACHD-High Risk Pregnancy Maternal Fetal Medicine (MFM) Clinic. Fellows are encouraged to participate in these clinics and help formulate management plans in a collaborative forum.
ACHD Weekly Schedule
Adult Congenital Heart Disease Clinic – AM & PM
Adult Congenital Echocardiography – AM & PM
Adult Congenital Heart Disease Clinic – AM & PM
Adult Congenital Heart Disease Clinic – AM & PM
Adult Congenital Advanced Imaging Cardiac MRI/CT Imaging – AM & PM or
Congenital Hemodynamic & Interventional Cardiac Catheterization – Am & PM
Learn more about the MSACHD at: https://www.mountsinai.org/care/heart/services/congenital-heart-disease
On the Inpatient Cardiovascular Consultation service fellows will encounter a vast array of complex cardiovascular disease including acute inpatient arrhythmias, valvular disease, pre-procedural evaluations, complex cardio-oncology issues, hypotension, syncope, heart failure, acute coronary syndromes, and much more in the 1,134 bed hospital. The fellows lead the service which includes housestaff and medical students.
Director: Gagan Sahni
Mount Sinai’s Cardio-Oncology program was established in 2013 to provide a multidisciplinary platform for close collaboration among cardiologists (cardio-oncologists) with medical oncologists, radiation oncologists and onco- surgeons, allowing us to customize the best cancer therapies for our patients balanced against the cardiotoxicity of cancer therapeutics. Mount Sinai’s Hess Center is a busy tertiary cancer center with a large volume of myeloma, solid and hematological tumors, and breast and lung cancer patients supported by a robust bone marrow transplant program, in addition to offering cutting edge clinical trials with immunotherapy, CAR-T & novel therapeutics. We provide our cancer patients efficient, compassionate and timely access to cardiology consultations, testing and cardiac interventions to facilitate oncological regimens tailor-made for best cancer survival rates balanced with minimizing the cardiac effects of chemotherapy, radiation, and other cancer therapeutics. Fellows have initiated and participated in clinical, imaging, basic science & outcomes research projects and have also written cardio-oncology chapters.
Director: Robert Rosenson, MD
Endocrinologist: Donald Smith, MD
The Cardiometabolic Unit has a dual mission of patient care and scientific investigation into mechanisms of disease and participation in phase 2 and phase 3 clinical trials with novel lipoprotein modifying agents and anti-inflammatory therapies. The program has a long-standing tradition of mentorship and career development of trainees interested in lipoprotein disorders and cardiovascular disease prevention.
We provide care for large numbers of patients with monogenic lipoprotein disorders, and provide comprehensive strategies for primary and secondary prevention of cardiovascular diseases. Outpatient sessions are conducted daily in the Lauder Cardiovascular Center by two physicians (cardiologist and diabetologist) with support from a full-time nurse practitioner. We provide services from a registered dietician and work with the Cardiac Rehabilitation program to implement exercise prescriptions and exercise sessions. The ongoing research involves federally sponsored and industry supported research including investigator initiated trials and multicenter phase 2 and phase 3 clinical trials in the fields of lipoprotein disorders, inflammation and rheology. Other major areas of investigation include the use of large data to study cardiovascular outcomes. These projects have involved databases from MediCare, Marketscan, REGARDS and CARDIA.
Director: Jeff Olin, DO
With an internationally recognized faculty, the Mount Sinai Vascular Medicine section provides a comprehensive approach to patients with vascular disease through a collaborative relationship with vascular surgery, interventional radiology, peripheral interventional cardiology, rheumatology, neurology, and neuroradiology. The fellow will spend time in the outpatient clinics, inpatient consultations, vascular diagnostic laboratory and have exposure to endovascular and surgical procedures. The Mount Sinai non-invasive diagnostic laboratory performs in excess of 10,000 exams per year.
All clinical cardiology fellows at Mount Sinai receive Core Cardiology Training Symposium (COCATS) Level I training in vascular medicine. Level II and III training are also available. Level I fellows are trained in the evaluation and management of a wide array of simple and complex arterial, venous, and lymphatic diseases including peripheral artery disease, acute arterial occlusion, carotid artery disease, renal artery disease, arteriopathies resulting in aortic, coronary, peripheral arterial aneurysms and dissections, large vessel, vasculitis, venous, thromboembolism, lymphedema and fibro-muscular dysplasia.
Learn more about Vascular and Aortic Disease.
Level II Training:
Level II training provides the expertise necessary for fellows wishing to pursue a career in vascular medicine and to direct a vascular diagnostic laboratory. The fellow will be trained in noninvasive vascular laboratory techniques involving vascular ultrasound and other imaging techniques such as computed tomographic angiography (CTA), magnetic resonance angiography (MRA) and catheter-based angiography. Fellows completing Level II training are qualified to sit for the American Board of Vascular Medicine general examination and the Registered Physicians in Vascular Ultrasound (RPVI) examination.